课题基金 / 基金详情

CIRP通过调控巨噬细胞极化参与急性肝衰竭发生的作用及机制研究

批准号:
82100654
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
毕建斌
依托单位:
学科分类:
肝损伤、修复与再生
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
毕建斌

项目摘要

结项摘要

相似基金

相关文献

中文摘要
巨噬细胞极化失衡是急性肝衰竭(ALF)细胞因子风暴形成的核心机制。冷休克蛋白CIRP是一种新的炎症因子,但其与巨噬细胞极化的关系尚不清楚。我们的预实验发现ALF患者血清CIRP显著增高;CIRP敲除鼠诱发ALF后细胞因子风暴减轻;CIRP刺激巨噬细胞后M1型细胞比例增高,M2型降低。我们应用SELEX技术筛选出一组能特异性结合CIRP并抑制其与受体结合的CIRP核酸适配体。因此我们假设:CIRP以自分泌的方式诱导巨噬细胞向M1型极化,促进ALF发生;CIRP核酸适配体能特异性抑制CIRP活性,缓解其致病效应。我们拟通过临床分析和体内外实验明确CIRP在ALF中的表达;利用CIRP基因敲除小鼠和重组蛋白揭示CIRP在ALF巨噬细胞极化中的作用及分子机制;同时筛选CIRP核酸适配体,验证其对CIRP的抑制作用和ALF的治疗效果。本项目将揭示ALF发生的新机制,为CIRP的靶向治疗提供新方法。
英文摘要
Imbalance of macrophage polarization plays a pivotal role in cytokine storm formation during acute liver failure (ALF). Cold-inducible RNA-binding protein (CIRP) is a newly identified inflammatory factor; however, it remains unknown whether CIRP regulates macrophage polarization. Our preliminary study showed that the level of serum CIRP was significantly increased in ALF patients, and the cytokine storm was alleviated after ALF model in CIRP knockout mice. Meanwhile, we found that the proportion of M1 type macrophages were increased and M2-type macrophages were decreased after CIRP stimulation. Moreover, we have screened a group of CIRP aptamers by using SELEX that can specifically bind to CIRP and inhibit its binding to the receptor. Therefore, we hypothesized that CIRP induces the M1-type polarization of macrophages in an autocrine way to promote the occurrence of ALF. CIRP aptamer may specifically inhibit the activity of CIRP and alleviate its pathogenic effect. We intend to identify the expression of CIRP in ALF through clinical analysis and basic study. Meanwhile, CIRP knockout mice and CIRP recombinant protein will be used to explore the role and mechanism of CIRP in macrophages polarization in ALF. Additionally, the effect of CIRP aptamer on CIRP activity and ALF will be verified. This project will propose a new theory of ALF occurrence and provide a new method for CIRP targeted therapy.
冷诱导RNA结合蛋白(CIRP)在炎症反应中的调控作用尚不明确,但其与急性肝损伤的潜在关联引起广泛关注。本研究旨在系统揭示CIRP在急性肝损伤中的关键作用及其分子机制,探索其临床治疗潜力。项目围绕CIRP的表达特征、免疫调控机制及靶向干预策略展开研究,通过临床数据分析、动物模型构建及体外实验,取得以下重要成果:①CIRP在急性肝损伤中的表达与促炎作用。临床分析显示,急性肝损伤患者血清CIRP浓度显著升高,且与疾病严重程度(APACHEII、SOFA评分及ALT水平)呈正相关。动物模型(APAP、LPS/D-Gal、CLP)中,CIRP敲除小鼠的肝损伤显著减轻,血清炎症因子(TNF-α、IL-6)水平下降,证实CIRP通过加剧炎症反应促进肝损伤。②CIRP调控巨噬细胞极化的分子机制。CIRP通过结合TLR4受体,激活JAK1/STAT1和SOCS3/STAT3信号通路,促进巨噬细胞向M1型(促炎型)极化,抑制M2型(抗炎型)极化,并上调iNOS、CD11c等M1标志物表达。③CIRP核酸适配体的开发与治疗疗效。 通过SELEX技术筛选出高亲和力CIRP核酸适配体,验证其可阻断CIRP-TLR4相互作用。在CLP诱导的肝损伤、急性胰腺炎及肺损伤模型中,适配体显著降低炎症因子水平,减轻组织损伤,展现出临床应用潜力。④CIRP与中性粒细胞外诱捕网(NETs)及Th17分化的关联。CIRP敲除小鼠的NETs相关蛋白(H3Cit、MPO)表达减少,脓毒症肝损伤减轻;同时,CIRP通过IL-6R/STAT3通路协同TGF-β诱导Th17细胞分化,加剧炎症反应。⑤热休克蛋白的保护作用。发现HSF2BP通过调控HSF2/HSP70/MAPK信号通路,在急性肝损伤中发挥保护作用,为肝衰竭治疗提供新方向。科学意义与应用前景: 本研究首次系统阐明CIRP通过多维度机制(巨噬细胞极化、NETs形成、Th17分化)加剧急性肝损伤的分子基础,填补了CIRP在炎症调控中的理论空白。CIRP核酸适配体的成功开发为急性炎症性疾病提供了新型治疗策略。
国内基金
海外基金